Virpax Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$15,189,508 over the previous period. Total operating expenses were $15,689,788.
Profit Margin
| 2018 | 0 | -2.64M | |
|---|---|---|---|
| 2019 | 0 | -3.43M | |
| 2020 | 0 | -4.48M | |
| 2021 | 0 | -12.14M | |
| 2022 | 0 | -21.45M | |
| 2023 | 0 | -15.18M |
VRPX Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 5.11M | 10.76M | 4.83M | 1.29M | 622.74K | 1.14M |
Selling and marketing | 4M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 15.68M | 21.84M | 12.02M | 4.19M | 3.18M | 2.62M |
Operating income | -15.68M | -21.84M | -12.02M | -4.19M | -3.18M | -2.62M |
Other income (expenses), net | 500.28K | 194.41K | -30.56K | -143.93K | -124.64K | -14.97K |
Income before tax | -15.18M | -21.65M | -12.05M | -4.33M | -3.30M | -2.64M |
Income tax expense | 0 | -194.41K | 92.82K | 147.93K | 124.64K | 0 |
Net income | -15.18M | -21.45M | -12.14M | -4.48M | -3.43M | -2.64M |
Earnings per share | ||||||
Basic EPS | -12.97 | -18.32 | -10.37 | -9.07 | -6.58 | -0.53 |
Diluted EPS | -12.97 | -18.32 | -10.37 | -9.07 | -6.58 | -0.53 |
| Data source | Data source | Data source | Data source |